Company presents study on the effectiveness of UV light to purify peritoneal dialysis catheter connections PuraCath Medical, an emerging company in the development of technologies to reduce infections in dialysis patients, announced today that it presented scientific data during Kidney Week 2014 demonstrating the ability to reduce bacterial growth in a simulated peritoneal dialysis delivery […]
This author has yet to write their bio.Meanwhile lets just say that we are proud puracath contributed a whooping 16 entries.
Entries by puracath
To advance scientific understanding of the kidney health and patient safety implications of new and existing medical products and to foster development of therapies for diseases that affect the kidney by creating a collaborative environment in which FDA and the greater nephrology community can interact to optimize evaluation of drugs, devices, biologics, and food products.
The 2014 BIO International Convention is June 23-26 at the San Diego Convention Center in San Diego, California. BIO 2014 conference under SBIR Innovation Zone
PuraCath Medical, Inc. Awarded NSF (National Science Foundation) SBIR Phase I Grant for Developing Innovative Catheter Design for PD Patients.
PuraCath Medical, Inc. Awarded NSF SBIR Phase II Grant for Novel Peritoneal Dialysis Catheter to Reduce Infections.